Cancro M P
Department of Pathology, 284 John Morgan Building, University of Pennsylvania School of Medicine, 36th and Hamilton Walk, Philadelphia, PA 19104-6082, USA.
Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii34-6. doi: 10.1136/ard.2006.058412.
The B lymphocyte stimulator (BLyS; also termed BAFF) family of ligands and receptors plays a central role in B lymphocyte development, selection, and homoeostasis. Members of this family can independently influence different B cell subsets, because the interactions between the two ligands and three receptors vary, and the receptors themselves are differentially expressed among developing, naive, and antigen experienced B cell subsets. These properties prompt careful assessment of how ablative therapies may influence the behaviour of upstream or downstream B lineage populations, as well as how the implementation and expectations of therapeutics targeting BLyS family members must be guided by knowledge of the B cell subsets contributing to pathogenesis.
B淋巴细胞刺激因子（BLyS；也称为BAFF）配体和受体家族在B淋巴细胞的发育、选择和稳态中起着核心作用。该家族成员可独立影响不同的B细胞亚群，因为两种配体与三种受体之间的相互作用各不相同，且这些受体在发育中的、未活化的以及经历过抗原刺激的B细胞亚群中表达各异。这些特性促使我们仔细评估消融疗法如何影响上游或下游B细胞谱系群体的行为，以及针对BLyS家族成员的治疗方法的实施和预期如何必须以对参与发病机制的B细胞亚群的了解为指导。
